These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3214462)

  • 1. Pseudocholinesterase and lipoproteins.
    Cucuiano M
    Atherosclerosis; 1988 Jul; 72(1):83-6. PubMed ID: 3214462
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum pseudocholinesterase activity in rabbits fed simvastatin.
    Van Lith HA; Meijer GW; Haller M; Beynen AC
    Biochem Pharmacol; 1991 Feb; 41(3):460-1. PubMed ID: 1994903
    [No Abstract]   [Full Text] [Related]  

  • 3. Simvastatin influences testicular steroidogenesis in human.
    Rossato M; Guarneri G; Lavagnini T; Padovan D; Foresta C
    Horm Metab Res; 1993 Sep; 25(9):503-5. PubMed ID: 8225207
    [No Abstract]   [Full Text] [Related]  

  • 4. The relationships between human serum pseudocholinesterase, lipoproteins, and apolipoproteins (APOHDL).
    Ryhänen RJ; Jauhianen MS; Laitinen MV; Puhakainen EV
    Biochem Med; 1982 Oct; 28(2):241-5. PubMed ID: 7181873
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cardiovascular pharmacology (VIII). The role of HMG CoA reductase inhibitors in the current treatment of hyperlipidemias].
    Carmena R
    Rev Esp Cardiol; 1995 Jan; 48(1):59-65. PubMed ID: 7878284
    [No Abstract]   [Full Text] [Related]  

  • 6. [Simvastatin].
    Burgmer U; Mohr K
    Dtsch Med Wochenschr; 1996 Jun; 121(23):769-70. PubMed ID: 8646995
    [No Abstract]   [Full Text] [Related]  

  • 7. Simvastatin and lipoprotein(a).
    Crook D; Sidhu M; Bruce R
    Lancet; 1992 Feb; 339(8788):313-4. PubMed ID: 1346327
    [No Abstract]   [Full Text] [Related]  

  • 8. Simvastatin in the secondary prevention of coronary heart disease.
    Assmann G
    Pharmacol Res; 1997 Mar; 35(3):161. PubMed ID: 9229399
    [No Abstract]   [Full Text] [Related]  

  • 9. Aldosterone secretion in patients treated with simvastatin and ACE inhibitors.
    Semplicini A; Valle R; Serena L; Rossi G; Pessina AC
    Am J Med; 1993 May; 94(5):559-560. PubMed ID: 8498408
    [No Abstract]   [Full Text] [Related]  

  • 10. Tolerability of simvastatin.
    Br J Hosp Med; 1989 Sep; 42(3):239. PubMed ID: 2790367
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of simvastatin on plasma lipids, lipoproteins and apoproteins (A1 and B). 24 cases of major primary hypercholesterolemia].
    Aubert I; Emmerich J; Charpak Y; Chanu B; Dachet C; Herlich D; Besseau M; Rouffy J; Jacotot B
    Presse Med; 1988 May; 17(18):901-4. PubMed ID: 2968595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simvastatin but not pravastatin has a direct inhibitory effect on rat and human myocyte proliferation.
    Corsini A; Raiteri M; Soma MR; Gabbiani G; Paoletti R
    Clin Biochem; 1992 Oct; 25(5):399-400. PubMed ID: 1490305
    [No Abstract]   [Full Text] [Related]  

  • 13. The 4S study: a critical review.
    Crepaldi G
    Pharmacol Res; 1997 Mar; 35(3):163. PubMed ID: 9229400
    [No Abstract]   [Full Text] [Related]  

  • 14. Simvastatin influences linoleic acid metabolism.
    van Doormaal JJ; Bos WJ; Muskiet FA; Doorenbos H
    Pharm Weekbl Sci; 1989 Aug; 11(4):134-5. PubMed ID: 2798037
    [No Abstract]   [Full Text] [Related]  

  • 15. Pseudocholinesterase and serum lipoproteins.
    Schouten JA; Mulder C; Beynen AC
    Atherosclerosis; 1987 Oct; 67(2-3):269-70. PubMed ID: 3675719
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparisons of effects of statins (atorvastatin, fluvastatin, lovastatin, pravastatin, and simvastatin) on fasting and postprandial lipoproteins in patients with coronary heart disease versus control subjects.
    Schaefer EJ; McNamara JR; Tayler T; Daly JA; Gleason JL; Seman LJ; Ferrari A; Rubenstein JJ
    Am J Cardiol; 2004 Jan; 93(1):31-9. PubMed ID: 14697462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of simvastatin on plasma levels of lipids, lipoproteins and apolipoproteins in primary hypercholesterolemia].
    Caruzzo C; Uslenghi E; Varbella F; Caruzzo E; Marcolongo M; Brusca A
    Minerva Cardioangiol; 1989 Dec; 37(12):509-15. PubMed ID: 2695857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simvastatin reduces forearm vascular responsiveness to norepinephrine.
    Abbott D; Daher A; Manwaring P; Howes LG
    Atherosclerosis; 1997 Jun; 131(2):263-4. PubMed ID: 9199281
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of simvastatin and fenofibrate on the fatty acid composition of hypercholesterolaemic patients.
    Agheli N; Jacotot B
    Br J Clin Pharmacol; 1991 Oct; 32(4):423-8. PubMed ID: 1958434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial effects of statins.
    Mikhailidis DP; Ganotatis ES; Jagroop IA; Winder AF
    Lancet; 1996 Dec; 348(9041):1582-3. PubMed ID: 8950892
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.